Medicare Part D coverage · 1.56 · RxCUI 1921081
1.56 ML abaloparatide 2 MG/ML Pen Injector [Tymlos]
Per the CMS 2026 Part D formulary file, 1.56 ML abaloparatide 2 MG/ML Pen Injector [Tymlos] is covered by 2,783 Medicare Part D plans (55.1% of enrollable products), averaging Tier 4.2, with prior authorization required on 88.5% of covering formularies.
- 55.1%
- Plan coverage
- 2,783
- Plans covering
- T4.2
- Avg tier
- 88.5%
- Prior auth required
What the CMS Formulary Data Shows for 1.56 ML abaloparatide 2 MG/ML Pen Injector [Tymlos]
Per the CMS 2026 Part D formulary file, 1.56 ML abaloparatide 2 MG/ML Pen Injector [Tymlos] (RxNorm concept RXCUI 1921081, generic name 1.56) appears on 217 distinct formulary files spanning 2,783 Medicare Part D plan offerings - 55.1% of enrollable Part D products, mid-range placement; shopping across contracts changes access. Tier placement ranges from Tier 1 to Tier 6, with a cross-plan average of Tier 4.2.
Real-world access to 1.56 ML abaloparatide 2 MG/ML Pen Injector [Tymlos] depends on utilization management as much as tier placement: 88.5% of covering formularies require prior authorization. 0% require step therapy. 60.8% apply quantity limits.
Historical spending context from the CMS Medicare Part D Drug Spending Dashboard shows 12,979 Part D beneficiaries filled 1.56 ML abaloparatide 2 MG/ML Pen Injector [Tymlos] in 2023, with total plan-and-beneficiary spending of $197,623,448 and an average per-beneficiary annual cost of $15,226.40. The plan-by-plan detail below lists exactly which PDP and MA-PD contracts carry 1.56 ML abaloparatide 2 MG/ML Pen Injector [Tymlos] today.
Coverage Details
- Formularies covering
- 217
- Plans covering
- 2,783
- Coverage rate
- 55.1%
- Tier range
- Tier 1 – Tier 6
- Average tier
- Tier 4, Non-Preferred
Restrictions
- Prior authorization required
- 88.5% of formularies
- Step therapy required
- 0% of formularies
- Quantity limits
- 60.8% of formularies
2023 Medicare Spending
- Beneficiaries
- 12,979
- Total spending
- $197,623,448
- Avg per beneficiary
- $15,226.40
Tier Distribution Across Plans
Medicare Advantage Plans (MA-PD) Covering 1.56 ML abaloparatide 2 MG/ML Pen Injector [Tymlos]
100 Medicare Advantage plans with Part D drug coverage include this drug.
| Plan | Insurer | Tier | PA | Premium | States |
|---|---|---|---|---|---|
| ElderServe MAP (HMO D-SNP) | Elderserve Health, Inc. | T1 | Yes | $0 | NY |
| Cooperative Advantage (HMO D-SNP) | Group Health Cooperative OF EAU Claire | T1 | Yes | $0 | WI |
| Longevity Health Plan (PPO I-SNP) | Longevity Health Plan OF NEW Jersey Insurance Comp | T1 | Yes | $0 | NJ |
| Upper Peninsula Health Plan MI Coordinated Health (HMO D-SNP) | Upper Peninsula Health Plan, LLC | T1 | Yes | $0 | MI |
| CareSource Dual Advantage (HMO D-SNP) | Caresource Georgia Co. | T1 | Yes | $0 | GA |
| HAP CareSource MI Coordinated Health (HMO D-SNP) | HAP Caresource | T1 | Yes | $0 | MI |
| PruittHealth Premier D-SNP (HMO D-SNP) | Pruitthealth Premier, Inc. | T1 | No | $0 | GA |
| Simpra Advantage Dual Care (PPO D-SNP) | Simpra Advantage, Inc. | T1 | No | $0 | AL |
| Gold Coast Health Plan Total Care Advantage (HMO D-SNP) | Ventura County Medi-Cal Managed Care Commission | T1 | Yes | $0 | CA |
| Blue Cross Medicare Advantage Dual Care Plus (HMO D-SNP) | Health Care Service Corporation | T1 | Yes | $0 | NM |
| Blue Cross MA Dual Care Plus Preferred (PPO D-SNP) | Health Care Service Corporation | T1 | Yes | $0 | NM |
| Horizon NJ TotalCare (HMO D-SNP) | Horizon Healthcare OF NEW Jersey, Inc. | T1 | Yes | $0 | NJ |
| SecureBlue (HMO D-SNP) | HMO Minnesota | T1 | Yes | $0 | MN |
| Hamaspik Medicare Choice (HMO D-SNP) | Hamaspik, Inc. | T1 | Yes | $0 | NY |
| SeniorCare Complete (HMO D-SNP) | South Country Health Alliance | T1 | Yes | $0 | MN |
| AbilityCare (HMO D-SNP) | South Country Health Alliance | T1 | Yes | $0 | MN |
| Alameda Alliance Wellness (HMO D-SNP) | Alameda Alliance FOR Health | T1 | Yes | $0 | CA |
| Elevate Medicare Choice (HMO D-SNP) | Denver Health Medical Plan, Inc. | T1 | Yes | $0 | CO |
| AllCare Advantage Redwood Rx (HMO D-SNP) | Allcare Health Plan, Inc. | T1 | Yes | $0 | OR |
| PrimeWest Senior Health Complete (HMO D-SNP) | Primewest Rural MN Health Care Access Initiative | T1 | Yes | $0 | MN |
Show the next 30 plans
| Prime Health Complete (HMO D-SNP) | Primewest Rural MN Health Care Access Initiative | T1 | Yes | $0 | MN |
| Alterwood Advantage Dual Secure (HMO D-SNP) | Alterwood Advantage, Inc. | T1 | Yes | $0 | MD |
| Nascentia Dual Advantage (HMO D-SNP) | Visiting Nurse Association OF Central NEW York | T1 | Yes | $0 | NY |
| Provider Partners Pennsylvania Community Plan (HMO I-SNP) | Provider Partners Health Plan OF Pennsylvania, Inc | T1 | Yes | $0 | PA |
| Provider Partners North Carolina Community Plan (HMO I-SNP) | Provider Partners Health Plan OF North Carolina | T1 | Yes | $0 | NC |
| Provider Partners Indiana Community Plan (HMO I-SNP) | Provider Partners Health Plan OF Indiana | T1 | Yes | $0 | IN |
| Provider Partners Missouri Community Plan (HMO I-SNP) | Provider Partners Health Plan OF Missouri, Inc. | T1 | Yes | $0 | MO |
| Abilis Health Community (HMO I-SNP) | Signature Advantage, LLC | T1 | Yes | $0 | KY, TN |
| Arkansas Integrated Providers (AIP) Dual Advantage (HMO D-SNP) | Arkansas Superior Select, Inc. | T1 | Yes | $0 | AR |
| Community Care's Partnership Program (HMO D-SNP) | Community Care Health Plan, Inc. | T1 | Yes | $0 | WI |
| Platino Blindao (HMO D-SNP) | Triple S Advantage, Inc. | T1 | Yes | $0 | PR |
| Platino Enlace (HMO D-SNP) | Triple S Advantage, Inc. | T1 | Yes | $0 | PR |
| Platino Advance (HMO D-snp) | Triple S Advantage, Inc. | T1 | Yes | $0 | PR |
| Platino Plus (HMO D-snp) | Triple S Advantage, Inc. | T1 | Yes | $0 | PR |
| Longevity Health Plan (HMO I-SNP) | Longevity Health Plan OF Florida, Inc. | T1 | Yes | $4.80 | FL |
| Senior Care (HMO I-SNP) | Align Senior Care Florida, Inc. | T1 | No | $4.80 | FL |
| ProCare Advantage (HMO-POS I-SNP) | Procare Advantage, LLC | T1 | No | $4.80 | TX |
| ProCare Advantage - Kidney Care (HMO-POS C-SNP) | Procare Advantage, LLC | T1 | No | $4.80 | TX |
| American Health Advantage of Florida (HMO I-SNP) | American Health Plan OF FL, Inc. | T1 | No | $4.80 | FL |
| Blue Cross Medicare Advantage Dual Care Plus (HMO D-SNP) | Hcsc Insurance Services Company | T1 | Yes | $4.80 | TX |
| Gold Dialysis & Kidney Complete (HMO-POS C-SNP) | Gold Kidney OF Florida Inc | T1 | Yes | $4.80 | FL |
| Provider Partners Texas Advantage Plan (HMO I-SNP) | Provider Partners Health Plan OF Texas, Inc. | T1 | Yes | $4.80 | TX |
| Texas Independence Health Plan, Inc. (HMO I-SNP) | Texas Independence Health Plan, Inc. | T1 | Yes | $4.80 | TX |
| Texas Independence Community Plan (HMO I-SNP) | Texas Independence Health Plan, Inc. | T1 | Yes | $4.80 | TX |
| Blue Cross Medicare Advantage Dual Care Plus (HMO D-SNP) | GHS Insurance Company | T1 | Yes | $5.00 | OK |
| Longevity Health Plan (HMO I-SNP) | Longevity Health Plan OF Michigan, Inc. | T1 | Yes | $8.80 | MI |
| Senior Care (HMO I-SNP) | Align Senior Care MI, LLC | T1 | No | $8.80 | MI |
| Tribute Select (HMO-POS I-SNP) | Arkansas Superior Select, Inc. | T1 | Yes | $8.90 | AR |
| AgeRight Advantage Health Plan (HMO I-SNP) | Marquis Advantage, Inc. | T1 | No | $10.50 | OR, WA |
| ATRIO Special Needs Plan (HMO D-SNP) | Atrio Health Plans | T1 | Yes | $10.50 | OR |
Showing top 50 of 100 plans.
Frequently Asked Questions
Is 1.56 ML abaloparatide 2 MG/ML Pen Injector [Tymlos] covered by Medicare Part D?
Yes, 1.56 ML abaloparatide 2 MG/ML Pen Injector [Tymlos] is covered by 2,783 Medicare Part D plans (55.1% of all Part D formularies).
What tier is 1.56 ML abaloparatide 2 MG/ML Pen Injector [Tymlos] on Medicare Part D plans?
1.56 ML abaloparatide 2 MG/ML Pen Injector [Tymlos] averages Tier 4.2 across Part D plans, ranging from Tier 1 to Tier 6.
Does 1.56 ML abaloparatide 2 MG/ML Pen Injector [Tymlos] require prior authorization?
88.5% of Part D formularies require prior authorization for 1.56 ML abaloparatide 2 MG/ML Pen Injector [Tymlos]. Step therapy: 0%. Quantity limits: 60.8%.
How much does Medicare spend on 1.56 ML abaloparatide 2 MG/ML Pen Injector [Tymlos]?
In 2023, total Medicare Part D spending on 1.56 ML abaloparatide 2 MG/ML Pen Injector [Tymlos] was $197,623,448, covering 12,979 beneficiaries. The average spend per beneficiary was $15,226.40.
Read our methodology - how this data is sourced, computed, and verified.
Nationwide similar Part D drugs
Data-derived peers across the CMS Part D formulary extract: nearest average tier placement and nearest prior-authorization rate. Not therapeutic alternatives or same-generic strengths.
Closest average formulary tier
- 0.5 ML paliperidone palmitate 156 MG/ML Prefilled Syringe [Invega] T4.2
- 0.75 ML paliperidone palmitate 156 MG/ML Prefilled Syringe [Invega] T4.2
- 1 ML paliperidone palmitate 156 MG/ML Prefilled Syringe [Invega] T4.2
- 1.5 ML paliperidone palmitate 156 MG/ML Prefilled Syringe [Invega] T4.2
- clobazam 20 MG Oral Film [Sympazan] T4.2
- penicillamine 250 MG Oral Tablet T4.2
Similar prior-authorization rate
- 0.6 ML pegfilgrastim 10 MG/ML Prefilled Syringe [Neulasta] 88.4% PA
- 24 HR amantadine 137 MG Extended Release Oral Capsule [Gocovri] 88.2% PA
- 1 ML infliximab-dyyb 120 MG/ML Pen Injector [Zymfentra] 88% PA
- 3 ML apomorphine hydrochloride 10 MG/ML Cartridge 88% PA
- posaconazole 40 MG/ML Oral Suspension 88% PA
- carglumic acid 200 MG Tablet for Oral Suspension 89.1% PA